Viewing Study NCT00696332


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2026-02-06 @ 5:34 PM
Study NCT ID: NCT00696332
Status: COMPLETED
Last Update Posted: 2011-10-21
First Post: 2008-06-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALS View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALS View